News & Perspective

May 12, 2017

May 12, 2017

ASP Scan (Weekly) for May 12, 2017

Drug-resistance in Belgium
Potential Candida auris drug
Prehistoric enterococci
Non-susceptible pneumococcus
MRSA bacteremia
Overprescribing in the elderly
Stewardship in Asia Pacific

May 13, 2013

May 13, 2013

Evidence for close-contact spread of coronavirus grows

(CIDRAP News) – The World Health Organization (WHO) said the growing number of clusters of novel coronavirus (nCoV) cases offers increasing evidence that the virus can spread between people in close contact, as France confirmed the infection in a patient who shared a hospital room with the country's first case-patient.

Oct 07, 2011

Oct 07, 2011

Cuba, Southeast Asia among active spots for flu

(CIDRAP News) – Though influenza activity is low in most nations, some are seeing active transmission, including Cuba, Bolivia, Cameroon, and parts of Southeast Asia, the World Health Organization said today in an update.

Cuba and El Salvador have reported increasing circulation of influenza A (H3N2), a strain that peaked in Honduras in the middle of August.

Jan 28, 2011

Jan 28, 2011

US flu picking up pace; global activity mixed

(CIDRAP News) – Influenza activity in the United States last week increased in intensity and extent, sending more people to doctor's offices, the US Centers for Disease Control and Prevention (CDC) said today.

May 14, 2010

May 14, 2010

Surveillance reports show few pandemic flu hot spots

(CIDRAP News) – Low levels of flu activity across the United States resemble a summer pattern, while globally only sporadic pandemic flu activity is occurring with the most active areas in parts of the Caribbean and Central America, according to updates today.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Pages

Sort Results

 

Narrow results

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»